(TheNewswire)
Calgary , Alberta – TheNewswire - January 3 , 2024 – nDatalyze Corp. (“NDAT” or the“Corporation”) (CSE:NDAT) (OTC:NDATF) is pleased to update theCorporation’s business operations and explain its business model.
Introduction: In addressingthe pressing challenges of the mental health crisis, nDatalyzepresents a revolutionary solution – the YMI clinical decisionsupport system, an advanced data analysis tool that represents afundamental change to the way mental conditions are diagnosed andtreated. This transformative tool aims to substantially improve bothmental health diagnosis rates and treatment, thereby helping elevateoverall societal mental health. The following outlines the strategicapproach that underlies YMI’s business model.
The Problem: Aspublished in the National Library of Medicine ( https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007565/ ), b etween 2011and 2030, the cumulative economic output loss associated with mentaldisorders is projected to be US$ 16.3 trillion worldwide, making theeconomic output loss related to mental disorders comparable to that ofcardiovascular diseases, and higher than that of cancer, chronicrespiratory diseases, and diabetes. Unfortunately, c urrent mental condition diagnostic methods are wrong overhalf the time; essentially a coin toss that is often followedby inappropriate drug prescriptions with poor results and unwantedside effects. This prevalent"trial-and-error" approach hinders patient well-being,congests mental health systems, and contributes to an overall declinein societal mental health.
YMI Solution: YMI addressesthe root causes of misdiagnosis by leveraging an objective, fact-basedReference Database and clinician-guided machine-learning algorithms.This approach replaces subjective patient opinions with well-informeddiagnostic predictions that are consistent, rapid, and less biased;fundamentally altering the diagnostic and treatment landscape.
Strategic Approach with a Three-StepStrategy: YMI's evolution involves three crucial steps – 1.creating the system, 2. establishing credibility through clinicalstudies, and 3. penetrating the market through a series ofrelationships. We have already completed Step 1 – YMI is fullyfunctional and online today.
Step 2 - Clinical Studies forCredibility: Ongoing studies to involve the Canadian MentalHealth Association, and renowned professionals, Dr. Andrew Greenshaw,Dr. Bo Cao, and Dr. Dale Stevens, aim to validate YMI's effectivenessand explore the benefits of DNA data integration.? News releasereferences are:
Dec 21, 2023 https://quotemedia.com/portal/quote?qm_symbol=NDAT%3ACNX&qmodStoryID=5772724448358146
Dec 18, 2023 https://quotemedia.com/portal/quote?qm_symbol=NDAT%3ACNX&qmodStoryID=8848133407154159
Nov 14, 2023 https://quotemedia.com/portal/quote?qm_symbol=NDAT%3ACNX&qmodStoryID=5541047718403320
Step 3 - Market Penetration: To become the preferred mental condition diagnostic tool across Canadaand the US, YMI aims to forge relationships with governmental healthauthorities and health insurance companies, as is evident in recentnews releases.
Revenue Generation: Usage Feesand Licensing: nDatalyze anticipates recurring revenue through usagefees for each YMI system use, and/or licensing agreements. Targetmarkets include governmental health care systems, private health careinsurers, risk-based businesses like insurance companies, airlines,police & security, and trucking/shipping industries.
Capital Sufficiency: Thecorporation has ample capital to fund ongoing studies.
Reporting: Preliminary resultsfrom clinical studies are expected within the next 120 days, withupdates on the progress thereafter.
About YMI: YMIuses evidence-based, objective data from whole life experiences topredict individual mental states over time, and applies this knowledgetowards a fuller understanding of how mental health develops, and howto improve mental wellbeing. YMI combines supervised machine-learningwith a proprietary Reference Database to predict an individual’spredisposition toward a variety of common mental conditions, bothcurrent and forward in time.
nDatalyze's YMI is poised to revolutionize mental health diagnoseswhile ensuring a sustainable revenue stream. By strategicallyaddressing the causes of misdiagnosis, establishing credibilitythrough clinical studies, and targeting key markets, YMI aligns bothsocietal impact and financial success.
For Further Information, PleaseContact:
Dr. Keith Courtney, President (psychiatricaspects)
Email: drkeithcourtney@gmail.com
or
James Durward, CEO&CTO (technical aspects)
Email: jimd@ndatalyze.com
nDatalyze Website: https://www.ndatalyze.com
YMI Website: https://ymihealth.ca
Neither the Canadian Securities Exchange nor itsRegulation Services Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release. This news release does notconstitute an offer to sell or a solicitation of an offer to sell anyof the securities in the United States. The securities have not beenand will not be registered under the United States Securities Act of1933, as amended (the "U.S. Securities Act") or any statesecurities laws and may not be offered or sold within the UnitedStates or to U.S. Persons unless registered under the U.S. SecuritiesAct and applicable state securities laws or an exemption from suchregistration is available.
The information in this news release includes certaininformation and statements about management's view of future events,expectations, plans and prospects that constitute forward lookingstatements. These statements are based upon assumptions that aresubject to significant risks and uncertainties. Because of these risksand uncertainties and as a result of a variety of factors, the actualresults, expectations, achievements or performance may differmaterially from those anticipated and indicated by theseforward-looking statements. Any number of factors could cause actualresults to differ materially from these forward-looking statements aswell as future results. Although the Corporation believes that theexpectations reflected in forward looking statements are reasonable,it can give no assurances that the expectations of any forward-lookingstatements will prove to be correct. Except as required by law, theCorporation disclaims any intention and assumes no obligation toupdate or revise any forward-looking statements to reflect actualresults, whether as a result of new information, future events,changes in assumptions, changes in factors affecting suchforward-looking statements or otherwise.
Copyright (c) 2024 TheNewswire - All rights reserved.